Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
ABSTRACT Among the bacterial species included in the ESKAPE group, Acinetobacter baumannii is of great interest due to its intrinsic and acquired resistance to many antibiotics and its ability to infect different body regions. Cefiderocol (FDC) is a novel cephalosporin that is active against Gram-ne...
Main Authors: | Stefano Stracquadanio, Carmelo Bonomo, Andrea Marino, Dafne Bongiorno, Grete Francesca Privitera, Dalida Angela Bivona, Alessia Mirabile, Paolo Giuseppe Bonacci, Stefania Stefani |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-10-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.02347-22 |
Similar Items
-
Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysis
by: Christopher Longshaw, et al.
Published: (2023-12-01) -
Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance
by: Stamatis Karakonstantis, et al.
Published: (2022-05-01) -
Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9
by: Susie Gaillot, et al.
Published: (2023-08-01) -
Human Serum Proteins and Susceptibility of <i>Acinetobacter baumannii</i> to Cefiderocol: Role of Iron Transport
by: Casin Le, et al.
Published: (2022-03-01) -
Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii
by: Alessandra Oliva, et al.
Published: (2020-12-01)